PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model

Photochemistry and Photobiology

Volumn 89, Issue 4, 2013, Pages 942-952

  Rizvi, Imran ^a   Anbil, Sriram ^a   Alagic, Nermina ^a   Celli, Jonathan P ^a,b   Zheng, Lei Zak ^a   Palanisami, Akilan ^a   Glidden, Michael D ^a,b   Pogue, Brian W ^c   Hasan, Tayyaba ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^c DARTMOUTH COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; PORPHYRIN; RADIOSENSITIZING AGENT; VERTEPORFIN;

ARTICLE; CELL DEATH; CELL SURVIVAL; DRUG EFFECT; ENZYME ACTIVATION; EQUIPMENT; FEMALE; GENETICS; HUMAN; METABOLISM; OVARY TUMOR; PHOTOCHEMOTHERAPY; RADIATION EXPOSURE; TUMOR CELL LINE;

CASPASE 3; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME ACTIVATION; FEMALE; HUMANS; OVARIAN NEOPLASMS; PHOTOCHEMOTHERAPY; PORPHYRINS; RADIATION-SENSITIZING AGENTS;

EID: 84879845609     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/php.12065     Document Type: Article

References (135)

1. Huang, Z., (2005) A review of progress in clinical photodynamic therapy. Technol Cancer Res Treat 4, 283-293.
2. Celli, J. P., B. Q. Spring, I. Rizvi, C. L. Evans, K. S. Samkoe, S. Verma, B. W. Pogue, and, T. Hasan, (2010) Imaging and photodynamic therapy: Mechanisms, monitoring, and optimization. Chem. Rev. 110, 2795-2838
3. Hasan, T., B. Ortel, N. Solban, and, B. Pogue, (2006) Photodynamic therapy of cancer. In Cancer Medicine, (Edited by, D. W. Kufe, R. C. J. Bast, W. N. Hait, W. K. Hong, R. E. Pollock, R. R. Weichselbaum, J. F. Holland, and, E. I. Frei,), pp. 537-548. B.C. Decker, Inc., Hamilton, Ontario.
4. Smits, T., and, A. C. Moor, (2009) New aspects in photodynamic therapy of actinic keratoses. J. Photochem. Photobiol., B 96, 159-169.
5. Brown, S., E. Brown, and, I. Walker, (2004) The present and future role of photodynamic therapy in cancer treatment. Lancet Oncology 5, 497-508.
6. Wilson, B., and, M. Patterson, (2008) The physics, biophysics and technology of photodynamic therapy. Phys. Med. Biol. 53, 61.
7. Wilson, B. C., (2002) Photodynamic therapy for cancer: Principles. Can J Gastroenterol 16, 393-396.
8. Busch, T. M., S. M. Hahn, E. P. Wileyto, C. J. Koch, D. L. Fraker, P. Zhang, M. Putt, K. Gleason, D. B. Shin, M. J. Emanuele, K. Jenkins, E. Glatstein, and, S. M. Evans, (2004) Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients. Clin. Cancer Res. 10, 4630-4638.
9. Hahn, S. M., D. L. Fraker, R. Mick, J. Metz, T. M. Busch, D. Smith, T. Zhu, C. Rodriguez, A. Dimofte, and, F. Spitz, (2006) A Phase II Trial of Intraperitoneal Photodynamic Therapy for Patients with Peritoneal Carcinomatosis and Sarcomatosis. Clin. Cancer Res. 12, 2517.
10. DeLaney, T. F., W. F. Sindelar, Z. Tochner, P. D. Smith, W. S. Friauf, G. Thomas, L. Dachowski, J. W. Cole, S. M. Steinberg, and, E. Glatstein, (1993) Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int. J. Radiat. Oncol. Biol. Phys. 25, 445-457.
11. Sindelar, W. F., T. F. DeLaney, Z. Tochner, G. F. Thomas, L. J. Dachoswki, P. D. Smith, W. S. Friauf, J. W. Cole, and, E. Glatstein, (1991) Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I Study. Arch Surg 126, 318-324.
12. Hendren, S. K., S. M. Hahn, F. R. Spitz, T. W. Bauer, S. C. Rubin, T. Zhu, E. Glatstein, and, D. L. Fraker, (2001) Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Ann. Surg. Oncol. 8, 65-71.
13. Wilson, J. J., H. Jones, M. Burock, D. Smith, D. L. Fraker, J. Metz, E. Glatstein, and, S. M. Hahn, (2004) Patterns of recurrence in patients treated with photodynamic therapy for intraperitoneal carcinomatosis and sarcomatosis. Int. J. Oncol. 24, 711-717.
14. Wierrani, F., D. Fiedler, W. Grin, M. Henry, E. Dienes, K. Gharehbaghi, B. Krammer, and, W. Grunberger, (1997) Clinical effect of meso- tetrahydroxyphenylchlorine based photodynamic therapy in recurrent carcinoma of the ovary: Preliminary results. Br. J. Obstet. Gynaecol. 104, 376-378.
15. Agostinis, P., K. Berg, K. A. Cengel, T. H. Foster, A. W. Girotti, S. O. Gollnick, S. M. Hahn, M. R. Hamblin, A. Juzeniene, D. Kessel, M. Korbelik, J. Moan, P. Mroz, D. Nowis, J. Piette, B. C. Wilson, and, J. Golab, (2011) Photodynamic therapy of cancer: An update. CA Cancer J. Clin. 61, 250-281.
16. Jarvi, M., M. Patterson, and, B. Wilson, (2012) Insights into photodynamic therapy dosimetry: Simultaneous singlet oxygen luminescence and photosensitizer photobleaching measurements. Biophys. J. 102, 661-732.
17. Pogue, B. W., and, T. Hasan, (1997) A theoretical study of light fractionation and dose-rate effects in photodynamic therapy. Radiat. Res. 147, 551-559.
18. Zhou, X., B. W. Pogue, B. Chen, E. Demidenko, R. Joshi, J. Hoopes, and, T. Hasan, (2006) Pretreatment photosensitizer dosimetry reduces variation in tumor response. Int. J. Radiat. Oncol. Biol. Phys. 64, 1211-1220.
19. Aveline, B., T. Hasan, and, R. W. Redmond, (1994) Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA). Photochem. Photobiol. 59, 328-335.
20. Foster, T. H., D. F. Hartley, M. G. Nichols, and, R. Hilf, (1993) Fluence rate effects in photodynamic therapy of multicell tumor spheroids. Cancer Res. 53, 1249-1254.
21. Gibson, S. L., J. J. Havens, T. H. Foster, and, R. Hilf, (1997) Time-dependent intracellular accumulation of delta-aminolevulinic acid, induction of porphyrin synthesis and subsequent phototoxity. Photochem. Photobiol. 65, 416-421.
22. Finlay, J. C., S. Mitra, M. S. Patterson, and, T. H. Foster, (2004) Photobleaching kinetics of Photofrin in vivo and in multicell tumour spheroids indicate two simultaneous bleaching mechanisms. Phys. Med. Biol. 49, 4837-4860.
23. Weston, M., and, M. Patterson, (2011) Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival. Photochem. Photobiol. 87, 1129-1166.
24. Henderson, B., T. Busch, and, J. Snyder, (2006) Fluence rate as a modulator of PDT mechanisms. Lasers Surg. Med. 38, 489-582.
25. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and, Q. Peng, (1998) Photodynamic therapy. J. Natl Cancer Inst. 90, 889-905.
26. Hopper, C., (2000) Photodynamic therapy: A clinical reality in the treatment of cancer. Lancet Oncol 1, 212-219.
27. Moesta, K. T., W. R. Greco, S. O. Nurse-Finlay, J. C. Parsons, and, T. S. Mang, (1995) Lack of reciprocity in drug and light dose dependence of photodynamic therapy of pancreatic adenocarcinoma in vitro. Cancer Res. 55, 3078-3084.
28. Lilge, L., K. Molpus, T. Hasan, and, B. C. Wilson, (1998) Light dosimetry for intraperitoneal photodynamic therapy in a murine xenograft model of human epithelial ovarian carcinoma. Photochem. Photobiol. 68, 281-288.
29. Lee, S., K. Galbally-Kinney, M. Hinds, J. O'Hara, B. Pogue, A. Liang, T. Hasan, and, S. Davis, (2009) A singlet oxygen monitor as an in vivo photodynamic therapy dosimeter. SPIE Proceedings From Photodynamic Therapy: Back to the Future 7380, 738046.
30. Pogue, B. W., C. Sheng, J. Benevides, D. Forcione, B. Puricelli, N. Nishioka, and, T. Hasan, (2008) Protoporphyrin IX fluorescence photobleaching increases with the use of fractionated irradiation in the esophagus. Journal of Biomedical Optics 13, 10.
31. Samkoe, K. S., A. Chen, I. Rizvi, J. A. O'Hara, P. J. Hoopes, S. P. Pereira, T. Hasan, and, B. W. Pogue, (2010) Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models. Int. J. Radiat. Oncol. Biol. Phys. 76, 251-259.
32. Iinuma, S., K. T. Schomacker, G. Wagnieres, M. Rajadhyaksha, M. Bamberg, T. Momma, and, T. Hasan, (1999) In vivo fluence rate and fractionation effects on tumor response and photobleaching: Photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. Cancer Res. 59, 6164-6170.
33. Laubach, H., S. Chang, S. Lee, I. Rizvi, D. Zurakowski, S. Davis, C. Taylor, and, T. Hasan, (2008) In-vivo singlet oxygen dosimetry of clinical 5-aminolevulinic acid photodynamic therapy. Journal of Biomedical Optics 13, 050504.
34. Ortel, B., N. Chen, J. Brissette, G. P. Dotto, E. Maytin, and, T. Hasan, (1998) Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes. Br. J. Cancer 77, 1744-1751.
35. Ortel, B., D. Sharlin, D. O'Donnell, A. K. Sinha, E. V. Maytin, and, T. Hasan, (2002) Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells. Br. J. Cancer 87, 1321-1327.
36. Chang, S. K., I. Rizvi, N. Solban, and, T. Hasan, (2008) In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment. Clin. Cancer Res. 14, 4146-4153.
37. Aveline, B. M., T. Hasan, and, R. W. Redmond, (1995) The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA). Journal of Photochemistry and Photobiology. B, Biology 30, 161-169.
38. Dysart, J. S., and, M. S. Patterson, (2006) Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions. Photochemical & Photobiological Sciences: Official Journal of the European Photochemistry Association and the European Society for Photobiology 5, 73-81.
39. Jarvi, M., M. Niedre, M. Patterson, and, B. Wilson, (2006) Singlet oxygen luminescence dosimetry (SOLD) for photodynamic therapy: Current status, challenges and future prospects. Photochem. Photobiol. 82, 1198-1210.
40. Dysart, J. S., and, M. S. Patterson, (2005) Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro. Phys. Med. Biol. 50, 2597-2616.
41. Niedre, M. J., A. J. Secord, M. S. Patterson, and, B. C. Wilson, (2003) In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy. Cancer Res. 63, 7986-7994.
42. Weishaupt, K. R., C. J. Gomer, and, T. J. Dougherty, (1976) Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 36, 2326-2329.
43. Georgakoudi, I., and, T. H. Foster, (1998) Singlet oxygen- versus nonsinglet oxygen-mediated mechanisms of sensitizer photobleaching and their effects on photodynamic dosimetry. Photochem. Photobiol. 67, 612-625.
44. Georgakoudi, I., M. Nichols, and, T. Foster, (1997) The mechanism of Photofrin photobleaching and its consequences for photodynamic dosimetry. Photochem. Photobiol. 65, 135-144.
45. Aveline, B., and, R. Redmond, (1999) Can cellular phototoxicity be accurately predicted on the basis of sensitizer Photophysics? Photochem. Photobiol. 69, 306-316.
46. Potter, W. R., T. S. Mang, and, T. J. Dougherty, (1987) The theory of photodynamic therapy dosimetry: Consequences of photo-destruction of sensitizer. Photochem. Photobiol. 46, 97-101.
47. Fingar, V. H., W. R. Potter, and, B. W. Henderson, (1987) Drug and light dose dependence of photodynamic therapy: A study of tumor cell clonogenicity and histologic changes. Photochem. Photobiol. 45, 643-650.
48. Betz, C. S., W. Rauschning, E. P. Stranadko, M. V. Riabov, V. Albrecht, N. E. Nifantiev, and, C. Hopper, (2008) Optimization of treatment parameters for Foscan®-PDT of basal cell carcinomas. Lasers Surg. Med. 40, 300-311.
49. Mathews, M., E. Angell-Petersen, R. Sanchez, C.-H. Sun, V. Vo, H. Hirschberg, and, S. Madsen, (2009) The effects of ultra low fluence rate single and repetitive photodynamic therapy on glioma spheroids. Lasers Surg. Med. 41, 578-662.
50. Gibson, S. L., K. R. VanDerMeid, R. S. Murant, R. F. Raubertas, and, R. Hilf, (1990) Effects of various photoradiation regimens on the antitumor efficacy of photodynamic therapy for R3230AC mammary carcinomas. Cancer Res. 50, 7236-7241.
51. Foster, T. H., R. S. Murant, R. G. Bryant, R. S. Knox, S. L. Gibson, and, R. Hilf, (1991) Oxygen consumption and diffusion effects in photodynamic therapy. Radiat. Res. 126, 296-303.
52. Celli, J. P., I. Rizvi, C. L. Evans, A. O. Abu-Yousif, and, T. Hasan, (2010) Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model. Journal of Biomedical Optics 15, 051603-051610.
53. Rizvi, I., J. P. Celli, C. L. Evans, A. O. Abu-Yousif, A. Muzikansky, B. W. Pogue, D. Finkelstein, and, T. Hasan, (2010) Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. Cancer Res. 70, 9319-9328.
54. Cho, K. R., and, M. Shih Ie, (2009) Ovarian cancer. Annu. Rev. Pathol. 4, 287-313.
55. Bast, R. C. Jr, B. Hennessy, and, G. B. Mills, (2009) The biology of ovarian cancer: New opportunities for translation. Nat. Rev. Cancer 9, 415-428.
56. Siegel, R., D. Naishadham, and, A. Jemal, (2012) Cancer statistics, 2012. CA Cancer J. Clin. 62, 10-29.
57. Evans, S. M., K. D. Judy, I. Dunphy, W. T. Jenkins, W. T. Hwang, P. T. Nelson, R. A. Lustig, K. Jenkins, D. P. Magarelli, S. M. Hahn, R. A. Collins, M. S. Grady, and, C. J. Koch, (2004) Hypoxia is important in the biology and aggression of human glial brain tumors. Clin. Cancer Res. 10, 8177-8184.
58. Evans, S. M., K. D. Judy, I. Dunphy, W. T. Jenkins, P. T. Nelson, R. Collins, E. P. Wileyto, K. Jenkins, S. M. Hahn, C. W. Stevens, A. R. Judkins, P. Phillips, B. Geoerger, and, C. J. Koch, (2004) Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding. Cancer Res. 64, 1886-1892.
59. Bogaards, A., A. Varma, K. Zhang, D. Zach, S. K. Bisland, E. H. Moriyama, L. Lilge, P. J. Muller, and, B. C. Wilson, (2005) Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: Pre-clinical model and technology development. Photochem. Photobiol. Sci. 4, 438-442.
60. Stepp, H., T. Beck, T. Pongratz, T. Meinel, F.-W. Kreth, J. C. Tonn, and, W. Stummer, (2007) ALA and malignant glioma: Fluorescence-guided resection and photodynamic treatment. J. Environ. Pathol. Toxicol. Oncol. 26, 157-164.
61. Beck, T. J., F. W. Kreth, W. Beyer, J. H. Mehrkens, A. Obermeier, H. Stepp, W. Stummer, and, R. Baumgartner, (2007) Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX. Lasers Surg. Med. 39, 386-393.
62. Olzowy, B., C. S. Hundt, S. Stocker, K. Bise, H. J. Reulen, and, W. Stummer, (2002) Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid. J. Neurosurg. 97, 970-976.
63. Biel, M. A., (1998) Photodynamic therapy and the treatment of head and neck neoplasia. Laryngoscope 108, 1259-1268.
64. de Bree, R., and, C. R. Leemans, (2010) Recent advances in surgery for head and neck cancer. Curr. Opin. Oncol., 22, 186-193.
65. Rigual, N. R., K. Thankappan, M. Cooper, M. A. Sullivan, T. Dougherty, S. R. Popat, T. R. Loree, M. A. Biel, and, B. Henderson, (2009) Photodynamic therapy for head and neck dysplasia and cancer. Arch. Otolaryngol. Head Neck Surg. 135, 784-788.
66. Zhu, T. C., J. C. Finlay, and, S. M. Hahn, (2005) Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. J. Photochem. Photobiol., B 79, 231-241.
67. ClinicalTrials.gov (2010). Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer. Available at: http://clinicaltrials.gov/ct2/show/NCT00322699?cond=bladder+cancer&intr= photodynamic+therapy&rank=1. Accessed on 15 January 2013.
68. Chapman, M. H., and, S. P. Pereira, (2009) Cholangiocarcinoma: Improving biliary drainage with PDT. Photodiagnosis Photodyn Ther 6, 82-83.
69. Sandanayake, N. S., M. T. Huggett, S. G. Bown, B. W. Pogue, T. Hasan, and, S. P. Pereira, (2010) Photodynamic therapy for locally advanced pancreatic cancer: Early clinical results. In Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XIX, Vol. 7551 (Edited by, D. Kessel,), pp. 75510L-8. SPIE, Bellingham, WA, USA, Proceedings of the SPIE (Photonics West), San Francisco, CA, USA.
70. Bown, S. G., A. Z. Rogowska, D. E. Whitelaw, W. R. Lees, L. B. Lovat, P. Ripley, L. Jones, P. Wyld, A. Gillams, and, A. W. R. Hatfield, (2002) Photodynamic therapy for cancer of the pancreas. Gut 50, 549-557.
71. Ayaru, L., S. G. Bown, and, S. P. Pereira, (2005) Photodynamic therapy for pancreatic and biliary tract carcinoma. Int J Gastrointest Cancer 35, 1-13.
72. Kessel, D., and, N. L. Oleinick, (2009) Initiation of autophagy by photodynamic therapy. Methods Enzymol. 453, 1-16.
73. Oleinick, N., R. Morris, and, I. Belichenko, (2002) The role of apoptosis in response to photodynamic therapy: What, where, why, and how. Photochem. Photobiol. Sci. 1, 1-21.
74. Buytaert, E., M. Dewaele, and, P. Agostinis, (2007) Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. BBA-Reviews on Cancer 1776, 86-107.
75. Kessel, D., Y. Luo, Y. Deng, and, C. K. Chang, (1997) The role of subcellular localization in initiation of apoptosis by photodynamic therapy. Photochem. Photobiol. 65, 422-426.
76. Kessel, D., and, Y. Luo, (1998) Mitochondrial photodamage and PDT-induced apoptosis. Journal of Photochemistry and Photobiology B, Biology 42, 89-95.
77. Andrzejak, M., M. Price, and, D. H. Kessel, (2011) Apoptotic and autophagic responses to photodynamic therapy in 1c1c7 murine hepatoma cells. Autophagy 7, 979-984.
78. Casas, A., G. Di Venosa, T. Hasan, and, B. Al, (2011) Mechanisms of resistance to photodynamic therapy. Curr. Med. Chem. 18, 2486-2515.
79. Verma, S., G. M. Watt, Z. Mai, and, T. Hasan, (2007) Strategies for enhanced photodynamic therapy effects. Photochem. Photobiol. 83, 996-1005.
80. Solban, N., I. Rizvi, and, T. Hasan, (2006) Targeted photodynamic therapy. Lasers Surg. Med. 38, 522-531.
81. Gomer, C., A. Ferrario, M. Luna, N. Rucker, and, S. Wong, (2006) Photodynamic therapy: Combined modality approaches targeting the tumor microenvironment. Lasers Surg. Med. 38, 516-521.
82. Ferrario, A., and, C. J. Gomer, (2010) Targeting the tumor microenvironment using photodynamic therapy combined with inhibitors of cyclooxygenase-2 or vascular endothelial growth factor. Methods Mol. Biol. 635, 121-132.
83. Abu-Yousif, A. O., A. C. Moor, X. Zheng, M. D. Savellano, W. Yu, P. K. Selbo, and, T. Hasan, (2012) Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells. Cancer Lett. 321, 120-127.
84. Peng, T. I., C. J. Chang, M. J. Guo, Y. H. Wang, J. S. Yu, H. Y. Wu, and, M. J. Jou, (2005) Mitochondrion-targeted photosensitizer enhances the photodynamic effect-induced mitochondrial dysfunction and apoptosis. Ann. N. Y. Acad. Sci. 1042, 419-428.
85. Granville, D. J., J. G. Levy, and, D. W. Hunt, (1998) Photodynamic treatment with benzoporphyrin derivative monoacid ring A produces protein tyrosine phosphorylation events and DNA fragmentation in murine P815 cells. Photochem. Photobiol. 67, 358-362.
86. Belzacq, A. S., E. Jacotot, H. L. Vieira, D. Mistro, D. J. Granville, Z. Xie, J. C. Reed, G. Kroemer, and, C. Brenner, (2001) Apoptosis induction by the photosensitizer verteporfin: Identification of mitochondrial adenine nucleotide translocator as a critical target. Cancer Res. 61, 1260-1264.
87. Celli, J. P., N. Solban, A. Liang, S. P. Pereira, and, T. Hasan, (2011) Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines. Lasers Surg. Med. 43, 565-574.
88. Granville, D. J., J. G. Levy, and, D. W. Hunt, (1997) Photodynamic therapy induces caspase-3 activation in HL-60 cells. Cell Death Differ. 4, 623-628.
89. Granville, D. J., C. M. Carthy, D. W. Hunt, and, B. M. McManus, (1998) Apoptosis: Molecular aspects of cell death and disease. Lab. Invest. 78, 893-913.
90. Granville, D. J., C. M. Carthy, H. Jiang, G. C. Shore, B. M. McManus, and, D. W. Hunt, (1998) Rapid cytochrome c release, activation of caspases 3, 6, 7 and 8 followed by Bap31 cleavage in HeLa cells treated with photodynamic therapy. FEBS Lett. 437, 5-10.
91. Granville, D. J., and, D. W. Hunt, (2000) Porphyrin-mediated photosensitization-taking the apoptosis fast lane. Curr. Opin. Drug Discov. Devel. 3, 232-243.
92. Schmidt-Erfurth, U., and, T. Hasan, (2000) Mechanisms of Action of Photodynamic Therapy with Verteporfin for the Treatment of Age-Related Macular Degeneration. Surv. Ophthalmol. 45, 195-214.
93. Duska, L. R., M. R. Hamblin, J. L. Miller, and, T. Hasan, (1999) Combination photoimmunotherapy and cisplatin: Effects on human ovarian cancer ex vivo. J. Natl Cancer Inst. 91, 1557-1563.
94. del Carmen, M. G., I. Rizvi, Y. Chang, A. C. Moor, E. Oliva, M. Sherwood, B. Pogue, and, T. Hasan, (2005) Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo. J. Natl Cancer Inst. 97, 1516-1524.
95. Wilson, B. C., M. S. Patterson, and, L. Lilge, (1997) Implicit and explicit dosimetry in photodynamic therapy: A New paradigm. Lasers Med. Sci. 12, 182-199.
96. Dysart, J. S., G. Singh, and, M. S. Patterson, (2005) Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells. Photochem. Photobiol. 81, 196-205.
97. Wilson, B. C., (2007) Photodynamic therapy: Light delivery and dosage for second-generation photosensitizers. In Ciba Foundation Symposium- Photosensitizing Compounds: Their Chemistry, Biology and Clinical Use, Vol. 146. (Edited by, G. Bock, and, S. Harnett,). John Wiley & Sons, Ltd., Chichester, UK.
98. Whitacre, C. M., T. H. Satoh, L. Xue, N. H. Gordon, and, N. L. Oleinick, (2002) Photodynamic therapy of human breast cancer xenografts lacking caspase-3. Cancer Lett. 179, 43-49.
99. Luo, Y., C. K. Chang, and, D. Kessel, (1996) Rapid initiation of apoptosis by photodynamic therapy. Photochem. Photobiol. 63, 528-534.
100. Sheng, C., P. Jack Hoopes, T. Hasan, and, B. Pogue, (2007) Photobleaching-based dosimetry predicts deposited dose in ALA-PpIX PDT of rodent esophagus. Photochem. Photobiol. 83, 738-748.
101. Glidden, M. D., J. P. Celli, I. Massodi, I. Rizvi, B. W. Pogue, and, T. Hasan, (2012) Image-Based Quantification of Benzoporphyrin Derivative Uptake, Localization, and Photobleaching in 3D Tumor Models, for Optimization of PDT Parameters. Theranostics 2, 827-839.
102. Evans, C. L., A. O. Abu-Yousif, Y. J. Park, O. J. Klein, J. P. Celli, I. Rizvi, X. Zheng, and, T. Hasan, (2011) Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT. PLoS ONE 6, e23434.
103. Celli, J. P., I. Rizvi, A. R. Blanden, A. O. Abu-Yousif, B. Q. Spring, and, T. Hasan, (2011) Biologically-relevant 3D tumor arrays: Imaging-based methods for quantification of reproducible growth and analysis of treatment response. In Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XX, Vol. 7886, (Edited by, D. Kessel, and, T. Hasan,), pp. 788608: 1-8. SPIE, Bellingham, WA, USA, Proceedings of the SPIE (Photonics West), San Francisco, CA, USA.
104. Celli, J. P., I. Rizvi, C. L. Evans, A. O. Abu-Yousif, and, T. Hasan, (2010) Three-dimensional ovarian cancer models: Imaging and therapeutic combinations. In Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XIX, Vol. 7551, (Edited by, D. Kessel,), pp. 75510I: 1-10. SPIE, Bellingham, WA, USA, Proceedings of the SPIE (Photonics West), San Francisco, CA, USA.
105. Celli, J. P., I. Rizvi, A. R. Blanden, C. L. Evans, A. O. Abu-Yousif, B. Q. Spring, A. Muzikansky, B. W. Pogue, D. Finkelstein, and, T. Hasan, (2011) Imaging enabled platforms for development of therapeutics. In Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications III, Vol. 7910, (Edited by, S. Achilefu, and, R. Raghavachari,), pp. 791002:1-8. SPIE, Bellingham, WA, USA, Proceedings of the SPIE (Photonics West), San Francisco, CA, USA.
106. Zhong, W., J. P. Celli, I. Rizvi, Z. Mai, B. Q. Spring, S. H. Yun, and, T. Hasan, (2009) In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring. Br. J. Cancer 101, 2015-2022.
107. Ascencio, M., P. Collinet, M. O. Farine, and, S. Mordon, (2008) Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy. Lasers Surg. Med. 40, 332-341.
108. Ascencio, M., J. P. Estevez, M. Delemer, M. O. Farine, P. Collinet, and, S. Mordon, (2008) Comparison of continuous and fractionated illumination during hexaminolaevulinate-photodynamic therapy. Photodiagnosis Photodyn Ther 5, 210-216.
109. Estevez, J. P., M. Ascencio, P. Colin, M. O. Farine, P. Collinet, and, S. Mordon, (2010) Continuous or fractionated photodynamic therapy? Comparison of three PDT schemes for ovarian peritoneal micrometastasis treatment in a rat model. Photodiagnosis Photodyn Ther 7, 251-257.
110. Guyon, L., M. Ascencio, P. Collinet, and, S. Mordon, (2012) Photodiagnosis and photodynamic therapy of peritoneal metastasis of ovarian cancer. Photodiagn. Photodyn. Ther. 9, 16-47.
111. Molpus, K. L., M. R. Hamblin, I. Rizvi, and, T. Hasan, (2000) Intraperitoneal Photoimmunotherapy of Ovarian Carcinoma Xenografts in Nude Mice Using Charged Photoimmunoconjugates. Gynecol. Oncol. 76, 397-404.
112. Molpus, K. L., D. Kato, M. R. Hamblin, L. Lilge, M. Bamberg, and, T. Hasan, (1996) Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model. Cancer Res. 56, 1075-1082.
113. Zuluaga, M. F., and, N. Lange, (2008) Combination of photodynamic therapy with anti-cancer agents. Curr. Med. Chem. 15, 1655-1673.
114. Cengel, K. A., E. Glatstein, and, S. M. Hahn, (2007) Intraperitoneal photodynamic therapy. Cancer Treat. Res. 134, 493-514.
115. Menon, C., S. N. Kutney, S. C. Lehr, S. K. Hendren, T. M. Busch, S. M. Hahn, and, D. L. Fraker, (2001) Vascularity and uptake of photosensitizer in small human tumor nodules: Implications for intraperitoneal photodynamic therapy. Clin. Cancer Res. 7, 3904-3911.
116. Dysart, J. S., M. S. Patterson, T. J. Farrell, and, G. Singh, (2002) Relationship between mTHPC fluorescence photobleaching and cell viability during in vitro photodynamic treatment of DP16 cells. Photochem. Photobiol. 75, 289-295.
117. McIlroy, B. W., T. S., Mann, J. S., Dysart, and, B. C., Wilson, (2002) The effects of oxygenation and photosensitizer substrate binding on the use of fluorescence photobleaching as a dose metric for photodynamic therapy. Vib. Spectrosc. 28, 25-35.
118. Kessel, D., and, A. S. Arroyo, (2007) Apoptotic and autophagic responses to Bcl-2 inhibition and photodamage. Photochem. Photobiol. Sci. 6, 1290-1295.
119. Xue, L., S. Chiu, and, N. Oleinick, (2001) Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4. Oncogene 20, 3420-3427.
120. Winter, W., G. Maxwell, C. Tian, M. Sundborg, G. Rose, P. Rose, S. Rubin, F. Muggia, W. McGuire, and, G. Gynecologic Oncology, (2008) Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: A Gynecologic Oncology Group Study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 26, 83-92.
121. Hoskins, W. J., W. P. McGuire, M. F. Brady, H. D. Homesley, W. T. Creasman, M. Berman, H. Ball, and, J. S. Berek, (1994) The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am. J. Obstet. Gynecol. 170, 974-979; discussion 979-80.
122. Eisenhauer, E., N. Abu-Rustum, Y. Sonoda, C. Aghajanian, R. Barakat, and, D. Chi, (2008) The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer. Gynecol. Oncol. 108, 276-357.
123. Chi, D. S., E. L. Eisenhauer, O. Zivanovic, Y. Sonoda, N. R. Abu-Rustum, D. A. Levine, M. W. Guile, R. E. Bristow, C. Aghajanian, and, R. R. Barakat, (2009) Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol. Oncol. 114, 26-31.
124. Lee, S., M. E. Isabelle, K. L. Gabally-Kinney, B. W. Pogue, and, S. J. Davis, (2011) Dual-channel imaging system for singlet oxygen and photosensitizer for PDT. Biomedical Optics Express 2, 1233-1242.
125. Aveline, B. M., R. M. Sattler, and, R. W. Redmond, (1998) Environmental effects on cellular photosensitization: Correlation of phototoxicity mechanism with transient absorption spectroscopy measurements. Photochem. Photobiol. 68, 51-62.
126. Baran, T., and, T. Foster, (2012) Fluence rate-dependent photobleaching of intratumorally administered Pc 4 does not predict tumor growth delay. Photochem. Photobiol. 88, 1273-1279.
127. Xue, L. Y., S. M. Chiu, and, N. L. Oleinick, (2001) Photodynamic therapy-induced death of MCF-7 human breast cancer cells: A role for caspase-3 in the late steps of apoptosis but not for the critical lethal event. Exp. Cell Res. 263, 145-155.
128. Porter, A. G., and, R. U. Janicke, (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6, 99-104.
129. Kessel, D., and, J. J. Jr Reiners, (2007) Initiation of apoptosis and autophagy by the Bcl-2 antagonist HA14-1. Cancer Lett. 249, 294-299.
130. Donohue, E., A. Tovey, A. W. Vogl, S. Arns, E. Sternberg, R. N. Young, and, M. Roberge, (2011) Inhibition of autophagosome formation by the benzoporphyrin derivative verteporfin. J. Biol. Chem. 286, 7290-7300.
131. Osaki, T., S. Takagi, Y. Hoshino, M. Okumura, and, T. Fujinaga, (2006) Intracellular localization and concentration as well as photodynamic effects of benzoporphyrin derivative monoacid ring A in four types of rodent tumor cells. Cancer Lett. 243, 281-292.
132. Rizvi, I., T. A. Dinh, W. Yu, Y. Chang, M. E. Sherwood, and, T. Hasan, (2012) Photoimmunotherapy and irradiance modulation reduce chemotherapy cycles and toxicity in a murine model for ovarian carcinomatosis: Perspective and results. Isr. J. Chem. 52, 776-787.
133. Major, A. L., G. S. Rose, L. O. Svaasand, F. Ludicke, A. Campana, and, M. J. van Gemert, (2002) Intraperitoneal photodynamic therapy in the Fischer 344 rat using 5-aminolevulinic acid and violet laser light: A toxicity study. J. Photochem. Photobiol., B 66, 107-114.
134. Haber, D., N. Gray, and, J. Baselga, (2011) The evolving war on cancer. Cell 145, 19-24.
135. Bigelow, C. E., S. Mitra, R. Knuechel, and, T. H. Foster, (2001) ALA- and ALA-hexylester-induced protoporphyrin IX fluorescence and distribution in multicell tumour spheroids. Br. J. Cancer 85, 727-734.